瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02179 瑞科生物-B

未开盘 12-20 16:08:10

8.230

+0.230

+2.88%

最高8.230	最低7.790	成交量2,500
今开7.790	昨收8.000	日振幅5.50%
总市值39.75亿	流通市值26.02亿	总股本4.83亿
成交额1.99万	换手率0.00%	流通股本3.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"瑞科生物-B","latestPrice":8.23,"timestamp":1734682090015,"preClose":8,"halted":0,"volume":2500,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.268113,"marketStatus":"未开盘","marketStatusCode":0,"change":0.23,"latestTime":"12-20 16:08:10","open":7.79,"high":8.23,"low":7.79,"amount":19915,"amplitude":0.055,"askPrice":8.42,"askSize":1500,"bidPrice":7.82,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.220285204402882,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"listingDate":1648656000000,"adjPreClose":8,"openAndCloseTimeList":[[1734658200000,1734667200000],[1734670800000,1734681600000]],"volumeRatio":2.7932963078555773,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"2483315759","title":"瑞科生物-B盘中异动 快速下挫5.95%报7.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483315759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483315759?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:20","pubTimestamp":1731651612,"startTime":"0","endTime":"0","summary":"2024年11月15日下午盘14时20分，瑞科生物-B股票出现异动，股价快速跳水5.95%。资金方面，该股资金流入1.678万港元，流出8.909万港元。瑞科生物-B股票所在的生物技术行业中，整体涨幅为0.01%。预计此次发行将为瑞科生物募集约8亿元。此次定增完成后，扬子江药业将成为瑞科生物的控股股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111514201298e42d78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111514201298e42d78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2483847505","title":"瑞科生物获8亿参投背后：扬子江药业迈出并购第一步，疫苗还是一门好生意吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2483847505","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483847505?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:18","pubTimestamp":1731572292,"startTime":"0","endTime":"0","summary":"本文来源：时代周报 作者：杜苏敏获“隐形药王”扬子江药业8亿元参投，瑞科生物是什么来头？11月11日，瑞科生物（02179.HK）发布公告称，拟依据特别授权向认购方扬子江药业集团有限公司（下称“扬子江药业”）发行不超过1.43亿股内资股，认购价为每股5.59元，预计本次发行的募集资金约为8亿元（相当于瑞科生物定增后估值约...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Oexkkdx6VuNdDNtorKRrabvgCdH5tdR1uPeEwajLem3sIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Oexkkdx6VuNdDNtorKRrabvgCdH5tdR1uPeEwajLem3sIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241114A064FR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241114A064FR00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2482775723","title":"二代接班后，“三不做”的扬子江药业迈出并购第一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2482775723","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482775723?lang=zh_cn&edition=full","pubTime":"2024-11-12 17:54","pubTimestamp":1731405277,"startTime":"0","endTime":"0","summary":"此次定增完成后，扬子江药业将成为瑞科生物的控股股东。如今，扬子江药业是正是将瑞科生物收于麾下。2021年，徐镜人离世，其子徐浩宇接手掌舵扬子江药业。不过，扬子江药业的外延并购战略依旧十分谨慎。但如今看来，扬子江药业的企业战略已悄然发生变化。曾经“三不做”的扬子江药业，在徐浩宇的领导下，扬子江药业迈出了并购的第一步。首个标的是国产创新疫苗公司，而且，此标的扬子江药业已接触许久。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112175535abb9a32a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112175535abb9a32a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2482797641","title":"瑞科生物-B盘中异动 早盘股价大涨6.19%报8.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482797641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482797641?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:32","pubTimestamp":1731375142,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘09时32分，瑞科生物-B股票出现异动，股价快速拉升6.19%。截至发稿，该股报8.750港元/股，成交量8000股，换手率0.00%，振幅5.58%。资金方面，该股资金流入4.2225万港元，流出0港元。瑞科生物-B股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，绿竹生物-B、瑞科生物-B、方达控股涨幅较大，振幅较大的相关个股有绿竹生物-B、方达控股、科伦博泰生物-B，振幅分别为18.42%、6.80%、6.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112093222971a5d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112093222971a5d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2482791964","title":"瑞科生物(02149.HK)发行1.43亿股内资股 认购价每股5.59人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2482791964","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482791964?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:54","pubTimestamp":1731372840,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02149.HK) 公布，董事会于昨日(11日)会议上通过公司定向发行内资股的议案，拟依据特别授权向认购方发行不超过1.43亿股内资股。另外，瑞科生物于昨日与扬子江药业集团签署股份认购合同。据悉，扬子江药业集团有条件同意认购瑞科生物所发行共1.43亿股内资股，认购价为每股5.59元人民币。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240319143559072_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240319143559072_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395808/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1163","BK1161","02149","02179"],"gpt_icon":0},{"id":"2482573162","title":"瑞科生物(02179.HK)向扬子江药业发行1.43亿内资股  集资8亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573162","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573162?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:47","pubTimestamp":1731340020,"startTime":"0","endTime":"0","summary":"瑞科生物－Ｂ(02179.HK) 公布，建议向扬子江药业发行不超过1.43亿股内资股，每股作价5.59元人民币。预计募集资金约8亿人民币，将用于疫苗产品的研发和补充营运资金。完成后，扬子江药业将持有公司总股本22.86%。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220328112943795_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220328112943795_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395762/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2482820297","title":"瑞科生物-B拟依据特别授权向扬子江药业集团发行不超过1.43亿股内资股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482820297","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482820297?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:07","pubTimestamp":1731334061,"startTime":"0","endTime":"0","summary":"公司于2024年11月11日与认购方签署了股份认购合同，认购方有条件同意认购，且公司有条件同意发行共1.43亿股内资股，认购价为每股人民币5.59元。该认购价格较股份认购合同签订当日在联交所的H股收市价每股8.24港元折让约26.52%;本次发行的股份数量为不超过1.43亿股，分别约占本次发行后已发行内资股总数及已发行股份总数的48.03%及22.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111221024abb65490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111221024abb65490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2479781877","title":"智飞万泰沃森前三季度利润均腰斩，国产HPV疫苗还能怎么卷？","url":"https://stock-news.laohu8.com/highlight/detail?id=2479781877","media":"投资时间","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479781877?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:10","pubTimestamp":1730358635,"startTime":"0","endTime":"0","summary":"智飞生物、万泰生物、沃森生物三家国内主要HPV疫苗销售企业，三季报主要业绩指标均表现为同比下滑标点财经、投资时间网研究员 卓玛你知道九价HPV（人乳头瘤病毒）疫苗吗？该疫苗美国获批至今不过十年，国内获批至今仅有六年，但进口的默沙东九价HPV疫苗已不再一针难求。更有甚者，国产的二价疫苗早已在政府集采中身陷价格战...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OvrH1Xa33Zh5DOXzShQ7irRrO1OxUPSQyVOPqmlG3y9xYAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OvrH1Xa33Zh5DOXzShQ7irRrO1OxUPSQyVOPqmlG3y9xYAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241031A05R0N00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241031A05R0N00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["MRK","LU0238689110.USD","09633","LU0266013472.USD","LU1093756325.SGD","LU1057294990.SGD","LU0265550359.USD","LU0289739699.SGD","BK4559","BK4588","LU1066053197.SGD","LU1917777945.USD","IE0002141913.USD","IE00BBT3K403.USD","LU1116320737.USD","BK1161","BK4516","LU0070302665.USD","LU1066051225.USD","LU1037948541.HKD","LU0965509283.SGD","LU0058720904.USD","LU1934455863.HKD","LU0203345920.USD","LU0861579265.USD","IE00BJT1NW94.SGD","BK4550","LU1037948897.HKD","BK4007","IE00BSNM7G36.USD","LU0320765489.SGD","02179","LU1066051498.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0122379950.USD","BK4585","BK1589","LU1585245621.USD","BK4534","LU0985320562.USD","MSD","IE00BLSP4452.SGD","LU1093756168.USD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU1116320901.HKD","LU0965508806.USD","LU1023059063.AUD"],"gpt_icon":0},{"id":"2477718995","title":"瑞科生物-B盘中异动 临近收盘急速跳水5.05%报8.080港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477718995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477718995?lang=zh_cn&edition=full","pubTime":"2024-10-24 15:33","pubTimestamp":1729755205,"startTime":"0","endTime":"0","summary":"2024年10月24日临近收盘15时33分，瑞科生物-B股票出现异动，股价急速下跌5.05%。截至发稿，该股报8.080港元/股，成交量2000股，换手率0.00%，振幅4.94%。资金方面，该股资金流入8210港元，流出8390港元。瑞科生物-B股票所在的生物技术行业中，整体跌幅为1.96%。该信息摘要如下：格隆汇10月23日｜瑞科生物宣布，公司自主研发的新佐剂重组带状疱疹疫苗REC610已正式启动中国III期临床研究并完成首批受试者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024153325a1e61a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024153325a1e61a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2477765353","title":"瑞科生物－Ｂ(02179)股价下跌6.636%，现价港币$8.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2477765353","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477765353?lang=zh_cn&edition=full","pubTime":"2024-10-23 15:14","pubTimestamp":1729667640,"startTime":"0","endTime":"0","summary":"[下跌股]瑞科生物－Ｂ(02179) 股价在下午03:14比前收市价下跌6.636%，现股价为港币$8.02。至目前为止，今日最高价为$8.6，而最低价为$8.02。总成交量为5000股，总成交金额为港币$4.18万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2410231905/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2477328137","title":"瑞科生物(02179)自研新佐剂重组带状疱疹疫苗REC610启动中国III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2477328137","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477328137?lang=zh_cn&edition=full","pubTime":"2024-10-23 12:19","pubTimestamp":1729657181,"startTime":"0","endTime":"0","summary":"金吾财讯 | 瑞科生物(02179)宣布，公司自主研发的新佐剂重组带状疱疹疫苗REC610，已于近日正式启动中国III期临床研究并完成首批受试者入组。中国III期临床研究采用随机、双盲、安慰剂对照设计，在中国境内招募24,640例40岁及以上健康受试者，以评价REC610的保护效力、安全性及免疫原性。带状疱疹是一种常见的病毒感染性疾病，患者可能并发带状疱疹后神经痛，这种剧烈的神经疼痛严重影响患者生活质量。据统计，中国每年约有600万带状疱疹病例，且近年来其发病有逐步年轻化的趋势。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210510/ZGJjYTkxOGYyMGNlOTUwNjQ0NzUyMDkw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210510/ZGJjYTkxOGYyMGNlOTUwNjQ0NzUyMDkw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946344","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159646","III","BK4134","02179"],"gpt_icon":0},{"id":"2477328076","title":"瑞科生物重组带状疱疹疫苗启动中国III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2477328076","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477328076?lang=zh_cn&edition=full","pubTime":"2024-10-23 12:16","pubTimestamp":1729656961,"startTime":"0","endTime":"0","summary":"格隆汇10月23日｜瑞科生物宣布，公司自主研发的新佐剂重组带状疱疹疫苗REC610已正式启动中国III期临床研究并完成首批受试者入组。此前，REC610分别在菲律宾和中国开展以葛兰素史克Shingrix为阳性对照的I期临床研究。据统计，中国每年约有600万带状疱疹病例，且近年来其发病有逐步年轻化的趋势。目前，重组带状疱疹疫苗仅有Shingrix上市销售，国产替代需求强烈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410231216079f5801d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410231216079f5801d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2477328770","title":"瑞科生物(02179.HK)预防带状疱疹疫苗启动中国III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2477328770","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477328770?lang=zh_cn&edition=full","pubTime":"2024-10-23 12:11","pubTimestamp":1729656660,"startTime":"0","endTime":"0","summary":"瑞科生物-B公布，公司自主研发的新佐剂重组带状疱疹疫苗“REC610”，已于近日正式启动中国III期临床研究，并完成首批受试者入组。瑞科生物表示，“REC610”搭载由公司自主研发的新型佐剂“BFA01”，可促进产生高水平的VZV糖蛋白E特异性CD4+T细胞和抗体，拟用于在40岁及以上成人中预防带状疱疹。另外，“REC610”已于2023年10月，获得国家药品监督管理局签发的药物临床试验批准通知书，予以准许作为预防用3.3类生物制品，在中国开展I期和III期临床研究。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220328112943795_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220328112943795_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1390366&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","159646","02179"],"gpt_icon":0},{"id":"2477344771","title":"瑞科生物-B盘中异动 早盘快速跳水5.12%报8.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477344771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477344771?lang=zh_cn&edition=full","pubTime":"2024-10-23 11:22","pubTimestamp":1729653732,"startTime":"0","endTime":"0","summary":"2024年10月23日早盘11时22分，瑞科生物-B股票出现异动，股价快速跳水5.12%。截至发稿，该股报8.150港元/股，成交量1000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出8600港元。瑞科生物-B股票所在的生物技术行业中，整体涨幅为0.84%。瑞科生物-B公司简介：江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023112212ab6c6a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023112212ab6c6a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2473112507","title":"瑞科生物-B盘中异动 早盘股价大跌9.09%报8.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473112507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473112507?lang=zh_cn&edition=full","pubTime":"2024-10-07 10:06","pubTimestamp":1728266776,"startTime":"0","endTime":"0","summary":"2024年10月07日早盘10时06分，瑞科生物-B股票出现波动，股价大幅下挫9.09%。截至发稿，该股报8.000港元/股，成交量8000股，换手率0.00%，振幅9.55%。资金方面，该股资金流入5.2965万港元，流出1.7205万港元。瑞科生物-B股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，嘉和生物-B、复旦张江、昭衍新药涨幅较大，振幅较大的相关个股有嘉和生物-B、创胜集团-B、正大企业国际，振幅分别为63.03%、28.36%、20.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410071006169719e8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410071006169719e8cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2472986639","title":"瑞科生物-B盘中异动 下午盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472986639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472986639?lang=zh_cn&edition=full","pubTime":"2024-10-04 13:48","pubTimestamp":1728020923,"startTime":"0","endTime":"0","summary":"2024年10月04日下午盘13时48分，瑞科生物-B股票出现异动，股价急速拉升5.56%。截至发稿，该股报8.550港元/股，成交量1.75万股，换手率0.01%，振幅1.23%。瑞科生物-B股票所在的生物技术行业中，整体涨幅为4.99%。其相关个股中，复旦张江、君实生物、康希诺生物涨幅较大，振幅较大的相关个股有正大企业国际、复旦张江、方达控股，振幅分别为47.52%、32.43%、23.91%。瑞科生物-B公司简介：江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100413484398e3a8da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100413484398e3a8da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2472009666","title":"瑞科生物－Ｂ(02179)股价上升6.757%，现价港币$7.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2472009666","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472009666?lang=zh_cn&edition=full","pubTime":"2024-10-03 15:55","pubTimestamp":1727942100,"startTime":"0","endTime":"0","summary":"[上升股]瑞科生物－Ｂ(02179) 股价在下午03:55比前收市价上升6.757%，现股价为港币$7.9。至目前为止，今日最高价为$8.1，而最低价为$7.6。总成交量为3.95万股，总成交金额为港币$30.332万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410035245/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2472565724","title":"瑞科生物-B盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472565724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472565724?lang=zh_cn&edition=full","pubTime":"2024-10-02 10:45","pubTimestamp":1727837149,"startTime":"0","endTime":"0","summary":"2024年10月02日早盘10时45分，瑞科生物-B股票出现波动，股价快速下挫5.07%。截至发稿，该股报7.680港元/股，成交量1.75万股，换手率0.01%，振幅7.17%。瑞科生物-B股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，泰格医药、加科思-B、贝康医疗-B涨幅较大，振幅较大的相关个股有创胜集团-B、北海康成-B、泰格医药，振幅分别为37.50%、26.67%、24.19%。瑞科生物-B公司简介：江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100210454998e3a215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100210454998e3a215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2470240957","title":"瑞科生物-B盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470240957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470240957?lang=zh_cn&edition=full","pubTime":"2024-09-26 09:58","pubTimestamp":1727315883,"startTime":"0","endTime":"0","summary":"2024年09月26日早盘09时58分，瑞科生物-B股票出现波动，股价急速下挫5.18%。截至发稿，该股报8.050港元/股，成交量7500股，换手率0.00%，振幅8.95%。瑞科生物-B股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，乐普生物-B、康诺亚-B、绿竹生物-B涨幅较大，振幅较大的相关个股有乐普生物-B、瑞科生物-B、加科思-B，振幅分别为9.39%、8.95%、8.05%。瑞科生物-B公司简介：江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926095803a1dc97fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926095803a1dc97fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2469434375","title":"瑞科生物-B盘中异动 下午盘股价大跌8.89%报8.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469434375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469434375?lang=zh_cn&edition=full","pubTime":"2024-09-24 14:08","pubTimestamp":1727158112,"startTime":"0","endTime":"0","summary":"2024年09月24日下午盘14时08分，瑞科生物-B股票出现异动，股价快速下跌8.89%。截至发稿，该股报8.100港元/股，成交量4000股，换手率0.00%，振幅9.11%。资金方面，该股资金流入8910港元，流出2.63万港元。瑞科生物-B股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，华康生物医学、方达控股、锦欣生殖涨幅较大，振幅较大的相关个股有方达控股、科伦博泰生物-B、晶泰科技，振幅分别为11.86%、10.52%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924140832ab658af9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924140832ab658af9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0272},{"period":"6month","weight":-0.1025},{"period":"1year","weight":-0.1687},{"period":"ytd","weight":-0.2422}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗，人乳头瘤病毒（HPV）疫苗管线包括重组HPV九价候选疫苗REC603，重组HPV二价候选疫苗REC601及REC602，重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。","exchange":"SEHK","name":"瑞科生物-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞科生物-B,02179,瑞科生物-B股票,瑞科生物-B股票老虎,瑞科生物-B股票老虎国际,瑞科生物-B行情,瑞科生物-B股票行情,瑞科生物-B股价,瑞科生物-B股市,瑞科生物-B股票价格,瑞科生物-B股票交易,瑞科生物-B股票购买,瑞科生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}